ICD-10 Code C86.61 | Primary cutaneous CD30-positive T-cell prolif, in remission Symptoms, Diagnosis, Billing

Primary cutaneous CD30-positive T-cell proliferation, in remission, is a rare form of cutaneous lymphoma characterized by the proliferation of CD30-positive T-cells in the skin. This condition is clinically significant as it can indicate a potential progression to more aggressive forms of lymphoma if not monitored. The ICD-10 Code C86.61 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage patient outcomes.

What is ICD-10 Code C86.61 for Primary cutaneous CD30-positive T-cell prolif, in remission?

ICD-10 Code C86.61 represents Primary cutaneous CD30-positive T-cell proliferation, in remission, which is a type of skin lymphoma. This code is used when a patient has a confirmed diagnosis of this condition and is currently in remission. It is essential for clinical documentation and billing to accurately reflect the patient's status and ensure appropriate management and follow-up care.

ICD-10 Code C86.61 – Clinical Definition and Explanation of Primary cutaneous CD30-positive T-cell prolif, in remission

Primary cutaneous CD30-positive T-cell proliferation, in remission, is caused by the abnormal growth of T-cells that express the CD30 antigen. This condition can progress if not properly managed, necessitating medical attention. Regular monitoring is crucial to prevent potential complications.

Key Clinical Features:

• Presence of erythematous plaques or nodules on the skin.
• Histological confirmation of CD30-positive T-cell proliferation.
• Symptoms may include pruritus or discomfort in affected areas.
• Typically occurs in adults, with a higher prevalence in males.

ICD-10 Code C86.61 for Primary cutaneous CD30-positive T-cell prolif, in remission – SOAP Notes & Clinical Use

ICD-10 Code C86.61 is utilized in SOAP notes to document the patient's condition, including symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's health status.

What Does ICD-10 Code C86.61 for Primary cutaneous CD30-positive T-cell prolif, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C86.61 connects subjective patient reports and objective clinical findings to a formal diagnosis. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C86.61 – Primary cutaneous CD30-positive T-cell prolif, in remission

Management of Primary cutaneous CD30-positive T-cell proliferation, in remission, involves monitoring and supportive care to maintain remission.

Antibiotic Therapy:

• Not applicable as this condition is not infectious.

Supportive Care:

• Regular dermatological evaluations to monitor skin lesions.
• Topical corticosteroids to reduce inflammation.
• Patient education on skin care and monitoring for new lesions.

Infection Control:

• No specific infection control measures required.

How to Document Symptoms of Primary cutaneous CD30-positive T-cell prolif, in remission (ICD-10 C86.61) in SOAP Notes

Subjective:

• Patient reports occasional itching in the affected areas.
• No new lesions noted since last visit.
• Denies systemic symptoms such as fever or weight loss.
• History of previous CD30-positive T-cell proliferation.

Objective:

• Physical examination reveals stable erythematous plaques.
• No signs of infection or ulceration.
• Dermatological assessment shows no new lesions.
• Laboratory tests indicate normal blood counts.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Primary cutaneous CD30-positive T-cell prolif, in remission (ICD-10 Code C86.61)

Assessment:

• Diagnosis: Primary cutaneous CD30-positive T-cell proliferation, in remission.
• Severity: Currently stable with no evidence of progression.
• Triggers: Previous history of cutaneous lymphoma.
• Monitoring for potential recurrence is necessary.

Plan:

• Continue regular dermatological follow-ups every 3-6 months.
• Consider topical corticosteroids if inflammation increases.
• Educate patient on signs of recurrence and when to seek care.
• Schedule follow-up appointment in 3 months.

Treatment & Plan Section for ICD-10 Code C86.61 – Primary cutaneous CD30-positive T-cell prolif, in remission

• Topical corticosteroids as first-line treatment for localized lesions.
• Regular monitoring for any changes in skin condition.
• Patient education on skin care and awareness of symptoms.
• Follow-up appointments to assess treatment efficacy and skin health.

Using ICD-10 Code C86.61 for Primary cutaneous CD30-positive T-cell prolif, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings.
• Use the code in appropriate clinical settings to support billing.
• Align treatment plans with clinical guidelines for justified billing.
• Document any relevant comorbidities or complications.

Related ICD-10 Codes Often Used with Primary cutaneous CD30-positive T-cell prolif, in remission

• C86.60 – Primary cutaneous CD30-positive T-cell proliferation, unspecified
• C84.90 – Peripheral T-cell lymphoma, unspecified
• C84.91 – Peripheral T-cell lymphoma, not otherwise specified
• C85.90 – Non-Hodgkin lymphoma, unspecified

ICD-10 Code C86.61 in Medical Billing and Insurance for Primary cutaneous CD30-positive T-cell prolif, in remission

ICD-10 Code C86.61 is crucial for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings to support the diagnosis.
• Use the code in outpatient and inpatient settings as appropriate.
• Ensure that the patient's remission status is clearly noted.
• Include any associated procedures or treatments in the documentation.

Common CPT Pairings: